Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose comparison of remimazolam for daytime general anesthesia induction
ChiCTR2200056115Phase 4Not yet recruiting
- Sponsor
- Department of Anesthesiology, First Affiliated Hospital of Anhui Medical University
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam (3 arms), sponsored by Department of Anesthesiology, First Affiliated Hospital of Anhui Medical University. Primary endpoint: Time for BIS to fall to 60. Planned start Feb 2022; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2200056115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200056115.